CatalystWireBeta

UK small-cap RNS · 31 Mar 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 17:46
    Holding(s) in Company Holding
  2. 17:35
    Holding(s) in Company Holding
  3. 17:30
    Signing of Loan Release Deed agreement
    Pennpetro Energy plc, the company focused on developing strategic energy projects, announces that the Company has signed an important agreement including a Loan Release Deed ('Agreement') with Petroquest on 30th March 2026.
    Balance-sheet stress / refinancing outlook mixed +0.0% on the day
    Moved: Impaired Texas assets review: Chalk Talk 1H restart agreed, funded by RMD → Lease and JV agreed with Petroquest; restart timeline awaited · Suspension, going concern and pledged shares: Interims published; shares still suspended → c. $5m debt removed; shares still suspended
  4. 17:13
    Proposed Share Premium cancellation
    Cancelling the share premium account creates about £131.1m of distributable reserves to support the January buyback, future dividends and other purposes. It is an accounting step; no cash is returned now and it needs shareholder and Court approval.
    Capital return £131.1m · 45% of mcap +0.2% on the day
    Moved: Share buy-back programme: Still intention; consents awaited, replaces £5m programme → Reserves being created; buy-back still awaiting consents
  5. 07:15
    Half-year Results Results
    Interim results show Phalaborwa pilot plant progress, a new Uberaba EA and prices up, but the DFS is only due later in 2026. The US$14.6m raise was needed to fund both studies.
    Project milestones outlook positive +9.8% on the day
    Moved: Phalaborwa DFS and financing: DFS funded; due by end of 2026 → Pilot plant running; DFS funded · Uberaba Economic Assessment: PFS funded; completion in 2027 → EA published; PFS funded
  6. 07:02
    Operational Update – Daemaneng Operational Restart
    Daemaneng's funded restart and stockpile processing show production starting after flooding, but first deliveries only come by end Q2 2026 and there is still no revenue.
    Project milestones outlook mixed3 signals in 3 months – usually less than 1 −43.2% on the day
    Moved: DMS Plant production ramp-up: Upgrades due end-March; colluvial mining 2-3 weeks away → Restart under way; stockpile moving to plant · Capital-light Daemaneng operating model: Agreements signed; funding need flagged → Agreements signed; funding still needed · FY25 accounts delay and AIM suspension: Interims published; suspension status unclear → Funding sought; going-concern warning issued
  7. 07:00
    Valuation of Solar Development Pipeline
    ("Zenith" or the "Company") (LSE: ZEN; OSE: ZENA; XSAT: ZENA SDR), the international energy production and development company is pleased to announce that it has received an updated independent valuation of its Italian solar development pipeline (the …
    Disposal of a part (break-up) outlook positive +7.1% on the day
    Moved: Italian solar development pipeline: Pipeline 173.5 MWp; valuation awaited → Independent valuation received: EUR 54.7m · Partial sale of solar portfolio: Selective monetisation intended; no buyer → Sale plan quantified; no buyer named
  8. 07:00
    Update on Acquisition of Andacollo Project
    The Company is working diligently to satisfy closing conditions, including the approval of the TSX Venture Exchange (the "TSXV") and obtaining minority approval from the Company's shareholders.
    Project milestones outlook mixed3 acquisitions in 3 months – usually less than 1 −6.9% on the day
    Moved: Acquisition of Andacollo Oro: Share purchase agreement signed; approvals pending → Under TSXV review; approvals pending; shares halted · Going concern and funding: Larger deferred cash obligations, funding not yet arranged → Placing proceeds now redirected towards Andacollo · Indiana resource update and option payments: New NI 43-101 filed; PEA work starting → Indiana budget cut; PEA work still planned
  9. 07:00
    Launch of Underwritten Open Offer Fundraise
    Launches the underwritten £35m open offer at 175p to repay Lord Ashcroft's £30m bridge for PAM. It adds 18.39% to the share count, but the price is 2.8% below the latest close and the offer is underwritten.
    Large acquisition / reverse takeover £35.0m · 13% of mcapoutlook positivefirst since Oct 2023 +0.0% on the day
    Moved: PAM Healthcare acquisition: Unconditional; completion expected on or around 26 March → Completed 26 March; open offer launched to repay bridge
  10. 07:00
    Final Results Results
    The January cut to 2026 PBT of £60m-£65m is only confirmed, with trading in line. Profit is still expected to fall from 2025, so this is not a new warning.
    Project milestones in lineoutlook mixed +4.0% on the day
    Moved: Business and portfolio review: Nearing completion; core meat focus expected → Review completed; core meat focus confirmed (closed) · new: Seachill, Foppen, Dalco improvement plans – Improvement plans being implemented · Foppen US shipment disruption: Restrictions continue; US supply from Netherlands → Restrictions continue; £27.6m exceptional costs booked
  11. 07:00
    Chief Executive Officer (“CEO”) Appointment Board change
    Ends the leadership vacuum left by Rennie's November exit by making interim CEO Frampton permanent after an internal and external search, giving continuity as the strategy review and capital allocation work proceed.
    Capital return outlook positive +1.2% on the day
    Moved: CEO succession search: Interim CEO Frampton leading; no permanent CEO named → Frampton appointed permanent CEO (closed) · Capital allocation review: Second brand work ceased; review later in 2026 → Permanent CEO and new CFO now in place
  12. 07:00
    Statement regarding possible offer Offer
    Atlas's 65p cash approach confirms bid interest in BRCK, but the Board unanimously rejected it as undervaluing the company. Talks continue only if Atlas improves its price, so no premium is on offer yet.
    Takeover target outlook positivefirst since Oct 2023 +23.9% on the day
    Moved: new: Atlas possible offer – 65p proposal rejected; limited information shared
  13. 07:00
    Half-year Results Results
    Half-year revenue rose to $322,858 from $64,542 and net loss narrowed to $1.56m, but the gross loss widened to $394,493; cash of $3.4m after the raise funds the Sagebrush-1 test.
    Project milestones outlook positive −5.0% on the day
    Moved: Sagebrush-1 extended flow test: Awaiting operatorship; test still the focus → Awaiting final operatorship designation · Coyote Wash development: IMDA approved; moving to permitting and planning → IMDA approved; planning and permitting
  14. 07:00
    Half-year Results Results
    H1 revenue rose 51% to £504k and the net loss narrowed to £209k from £377k, supporting the channel-sales model. The board warns H1 growth should not be extrapolated and going-concern dependence on Parris remains.
    Disposal of a part (break-up) ahead of expectationsoutlook mixedfirst since Oct 2023 +0.0% on the day
    Moved: City Oil Field plastic-to-oil rollout: First Jeongeup RGO plant commissioned; PSA agreed, conditional → Korean plant certified and operating; UK/Arizona sites in discussion · Going concern uncertainty: Auditors flag material uncertainty; opinion unmodified → Net liabilities £304k; reliant on Parris support and pipeline · M2G channel sales growth: Orders and early FY26 sales rising → H1 revenue up 51%; orders ahead
  15. 07:00
    Financial report for 6 months to end-December 2025
    Copper revenue, margin and continuing EBITDA improved and net cash rose after the chrome sale. But Q2 output fell and FY2026 guidance is now under review, with the sold SA business loss-making.
    Disposal of a part (break-up) outlook mixedfirst since Oct 2023 −3.1% on the day
    Moved: new: FY2026 copper guidance – Guidance range under review · Molefe mine ramp-up: Ramp-up delayed by rains; target now Q4 FY2026 → Rain-hit; full haulage expected April 2026 · Roan dewatering facility upgrade: Commissioning due early March 2026 → Built; thickener running, final checks underway
  16. 07:00
    Subscription raises £11.1m from investors Fundraise
    Raises £11.1m at 20p, a 6.5% discount, from strategic investors including Traxys. It funds the company beyond Q2 2027 and covers the Phalaborwa DFS and Uberaba PFS, but it dilutes holders by about 8%.
    Project milestones £11.1m · 8% of mcapoutlook positivefirst since Oct 2023 +9.8% on the day
    Moved: Phalaborwa DFS and financing: Final pilot plant operating; DFS being finalised → DFS funded; due by end of 2026 · Uberaba Economic Assessment: EA published; Mosaic development agreement signed; PFS next → PFS funded; completion in 2027
  17. 07:00
    2025 Full Year Results Results
    The £85m equity raise at 270p completed on 30 March. It is a heavily discounted placing that dilutes existing holders, but with the debt equitisation and write-off it cuts net debt by c.£112m and avoids a lender-led outcome.
    New CEO / reset £85.0m · 93% of mcapoutlook positivefirst in 7 months +6.8% on the day
    Moved: Debt refinancing and recapitalisation: Shareholders approved all resolutions; admission due 30 March → Completed 30 March 2026; net debt cut (closed) · new: CEO recruitment and cost-saving programme – CEO search underway; savings programme expanded
  18. 07:00
    Financial Results for the Year Ended 30 June 2025 Results
    The audit overhang is cleared and FY25 losses narrowed, with cash of £862k. But the year had no material revenue and the 13 March accounts date was missed again.
    Project milestones outlook mixed −43.2% on the day
    Moved: DMS Plant production ramp-up: Flood recovery; upgrades under way → Upgrades due end-March; colluvial mining 2-3 weeks away · Capital-light Daemaneng operating model: Terms agreed on ROM; German talks continue → RoM terms agreed; logistics being refined; German talks ongoing · FY25 accounts delay and AIM suspension: Slipped again; final South African audit report due → Audited accounts published; AIM suspension status not stated
  19. 07:00
    Trading Update Trading update
    Q2 FY26 orders of about £1.9m and about £1.4m in March extend the order-book rebuild after the FY25 revenue slump. Firm FY26 visibility rises to over £5.1m.
    Transformational contract / build-out £5.1m · 113% of mcapoutlook positive +24.1% on the day
    Moved: Post-SDR contract and framework pipeline: Order book rebuilding; £4.5m FY26 sales firm → Order book growing; £5.1m FY26 sales visible
  20. 07:00
    Unaudited Interim Results Results
    The H1 loss widened to $9.0m as G&A and bond costs rose. Cash fell to $15.1m by 27 March, and with no further well operations planned, the story now depends on finding a farm-in partner.
    New CEO / reset outlook mixedfirst since Oct 2023 +3.1% on the day
    Moved: Complete US senior exchange listing, targeted for 2025 then Q4 2025 or Q1 2026: delayed → missed – US listing activities are suspended as part of cost cutting, so the Q1 2026 target for a US senior exchange listing will not be met. · 2023 strategy reset: Board reshaped; focus moving to engineering → Kodiak-first repositioning, cost cuts, new Board · Kodiak seismic reprocessing and Theta West-2: Seismic reprocessing started; well preparations only → Seismic reprocessing commissioned on NW Kodiak
  21. 07:00
    Update on Proposed Acquisition
    Alpha and Mercuria loans reach 31 March 2026 without repayment, and a further extension to 30 April is still only under discussion. Repayment relies on delayed diamond sales and an uncompleted placing.
    Balance-sheet stress / refinancing outlook mixed4 acquisitions in 3 months – usually less than 1 +0.0% on the day
    Moved: Gulf International Minerals reverse takeover: Conditional SPA; shares suspended, index deletion → Longstop extended to 5 May 2026; diligence largely done · Alpha and Mercuria loan default: Extended to 31 March 2026, conditional on progress → Further extension under discussion, not agreed · Zimbabwe diamond parcel sale: Phased sales of higher-quality stones continue → Dubai sales delayed; Antwerp channel in talks
  22. 07:00
    Half-year Results Results
    Revenue up 32.2% (11.4% proforma) and adjusted EPS up 15.4%, but adjusted EBITDA fell 3.6% with margin down to 16.9% as the cost base outweighs post-divestment revenue.
    Capital return outlook positivefirst in 6 months −2.9% on the day
    Moved: Earnings-enhancing M&A pursuit: Actively working on several potential targets → Several opportunities in discussion, none agreed · Share buyback programme: Ongoing; £1.1m returned by 31 December 2025 → Ongoing; £4.7m returned by 31 March 2026 · International partnership restructuring: Spanish office closing; Scandinavia distributor issue resolved → Madrid office closed; moving to strategic partnerships
  23. 07:00
    Half-year Results Results
    Half-year revenue slipped 6.9% as crypto trading softened after October, opex rose 35% and EBITDA swung to a loss, while cash nearly halved to £433k, undoing the strong Q1 momentum.
    Balance-sheet stress / refinancing outlook positivefirst since Oct 2023 −34.3% on the day
    Moved: BTaaS platform customer roll-out: Pilot revenue in Q1; formally launched October 2025 → Launched October 2025; early contributions only · XTP token treasury acquisition: Acquired for nil cost; related-party deal → Completed post-period; cash benefit expected · Founder and board share lock-in: Founder Alignment Deed signed 12 March 2026 → Three-year lock-in covers about 63.0% of shares
  24. 07:00
    Half-year Results Results
    Interim results show a shell with £124k of costs in six months and £97k cash, with no operating business; the Sudan gold pivot has no binding deal and funding is stretched.
    Delisting / take-private £0.0m · 1% of mcapoutlook mixedfirst since Oct 2023 −12.5% on the day
    Moved: Main Market delisting to Aquis: Proposed; shareholder approval pending → Shareholders approved; Aquis admission pending · Fundraise before end March: Planned, no terms → Replaced by £30k Chairman loan; raise deferred · Pivot to African gold processing: Review done; no binding agreements → Approved by shareholders; no binding agreements
  25. 07:00
    FY26 pre-close statement Trading update
    FY26 underlying PBT of c£92m only confirms prior guidance (consensus £93m, range £90-97m). It is not a raise, and sits slightly below the consensus midpoint.
    Turnaround plan with targets in lineoutlook mixedfirst since Oct 2023 +1.6% on the day
    Moved: Retail turnaround plan: Sequential Retail improvement; price cuts implemented → On track; price cuts and cost savings done · CMA vets market review: Provisional findings published; engaging with CMA → Final decision issued; no adverse impact expected (closed) · new: Dividend rebase and buyback – Announced after investor consultation
  26. 07:00
    Full Year Trading Update Trading update
    FY26 is in line at £10.2m, but FY27 guidance of £12m-£15m is cautious on later project starts and tight pricing, resetting the earlier 'unchanged' stance. Only the FY26 net debt beat softens it.
    Turnaround plan with targets in lineoutlook mixed, lowered +3.3% on the day
    Moved: Strategic review and transformation: Permanent CFO appointed; wider strategy pending → Review progressing; early changes implemented · Bridge remedial works programme: Progressing; £20m insurance received → Several programmes complete; £27.5m insurance received
  27. 07:00
    Half-year Results Results
    The announcement is interim results, not a guidance raise. Revenue grew 7% reported but only 2.5% at constant currency, and the operating loss widened to £11.4m. The outlook only expects H2 momentum to accelerate.
    Project milestones £36.3m · 13% of mcapoutlook positivefirst since Oct 2023 −1.9% on the day
    Moved: VLP Peanut PROTECT trial: Primary safety met; biomarker data positive → Phase IIb preparation underway · Potential equity raise: No raise agreed; £70m uncommitted debt funding available → No raise; £40m Hayfin debt drawn · Hong Kong dual listing: Still exploring potential dual primary listing → Still exploring dual primary listing
  28. 07:00
    Half-year Results Results
    Interim results show first diamond sales of only £26,000 and unrecognised HMS inventory, with the 2A Mining Right delayed in a DMRE backlog. Cash did rise to £664k after the £1.56m raise, and loan facilities mature 30 April 2026.
    Project milestones £0.0m · 0% of mcapoutlook positivefirst since Oct 2023 −15.8% on the day
    Moved: 2A Mining Right approval: Objection withdrawn; grant awaited; funding raised → Objection withdrawn; application in DMRE backlog · Aftan arbitration award enforcement: Award granted; Hebei challenging; enforcement ongoing → Hearing held January 2026; judgment awaited · HMS and diamond capacity expansion: Extra retail funding offered; upgrades under way → Upgrades under way; diamond sales begun
  29. 07:00
    Final Audited Results for the Year Ended 31 Dec 25 Results
    Statutory loss of £12.4m (2024: £2.7m profit) stems from a non-cash £10.9m Zenit reclassification charge. Cash rose to £5.4m after the ASX listing and Xinhai investment, so the balance sheet is stronger.
    Project milestones outlook positivefirst in 6 months −3.7% on the day
    Moved: Xinhai strategic investment in Dokwe: Definitive agreement signed; A$8m immediate funding → Investment completed; Xinhai joins board · Tavsan heap-leach ramp-up: c.135,000t loaded; ramp-up through Spring → In production; heap-leach commenced
  30. 07:00
    FY 2025 Results Results
    Strong 25% EBITDA growth ahead of expectations, increased unit volumes and continued product and platform expansion.
    Upgrade / downgrade cycle ahead of expectations +47.1% on the day
  31. 07:00
    Pre-close Trading Statement Trading update
    Faster Google search audience decline hits programmatic and ecommerce, cutting H1 EBITDA margin to 24-25% and FY to 25-27%, with H2 organic revenue now expected down low single digits, after on-track February trading.
    Turnaround plan with targets in lineoutlook negative, loweredfirst since Oct 2023 −23.7% on the day
    Moved: Mid-single digit organic revenue CAGR over 2023-26 with adjusted operating margi: pending → delayed – Lower H2 organic revenue and FY EBITDA margin of 25-27% put the 28-30% margin target and mid-single-digit organic growth CAGR at risk. · Deliver accelerating organic revenue growth beyond FY 2025.: on_track → missed – H2 organic revenue is now expected to decline, not accelerate, as programmatic and ecommerce fall. · Share buyback programme: £30m programme, about £5m bought → Buyback being accelerated
  32. 07:00
    Half-year Results Results
    Half-year loss of A$107.8m (EPS -104.73c vs -8.09c) driven by large case losses, A$99.2m unrealised losses and A$31.1m litigation service expense; restricted cash is almost all of the A$23.6m balance.
    Sale process / strategic review outlook mixedfirst since Oct 2023 −27.9% on the day
    Moved: Strategic review: Review continuing; results delayed to give update → Review approaching conclusion; no outcome yet

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note